Indobufen: Difference between revisions
Appearance
Content deleted Content added
Indobufen structure.svg |
Entranced98 (talk | contribs) Importing Wikidata short description: "Chemical compound" |
||
(18 intermediate revisions by 13 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
| Watchedfields = changed |
| Watchedfields = changed |
||
| verifiedrevid = |
| verifiedrevid = 447914993 |
||
| IUPAC_name = 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid |
| IUPAC_name = 2-(4-(1-Oxoisoindolin-2-yl)phenyl)butanoic acid |
||
| image = Indobufen structure.svg |
| image = Indobufen structure.svg |
||
| image2 = Indobufen ball-and-stick.png |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 26: | Line 29: | ||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 63610-08-2 |
| CAS_number = 63610-08-2 |
||
| ATC_prefix = B01 |
| ATC_prefix = B01 |
||
Line 36: | Line 40: | ||
| KEGG_Ref = {{keggcite|correct|kegg}} |
| KEGG_Ref = {{keggcite|correct|kegg}} |
||
| KEGG = D07141 |
| KEGG = D07141 |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 1765292 |
|||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
| ChemSpiderID = 96823 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=18 | H=17 | N=1 | O=3 |
| C=18 | H=17 | N=1 | O=3 |
||
| smiles = O=C(O)C(c1ccc(cc1)N3C(=O)c2ccccc2C3)CC |
|||
| molecular_weight = 295.333 g/mol |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C18H17NO3/c1-2-15(18(21)22)12-7-9-14(10-8-12)19-11-13-5-3-4-6-16(13)17(19)20/h3-10,15H,2,11H2,1H3,(H,21,22) |
|||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChIKey = AYDXAULLCROVIT-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Indobufen''' is a [[platelet aggregation inhibitor]].<ref>The Merck Index |
'''Indobufen''' is a [[platelet aggregation inhibitor]].<ref>{{cite book | title = The Merck Index | edition = 12th | page = 4991 }}</ref> It acts as a reversible [[Mechanism of action of aspirin|cyclooxygenase inhibitor]].<ref>{{cite journal | vauthors = Eligini S, Violi F, Banfi C, Barbieri SS, Brambilla M, Saliola M, Tremoli E, Colli S | display-authors = 6 | title = Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism | journal = Cardiovascular Research | volume = 69 | issue = 1 | pages = 218–26 | date = January 2006 | pmid = 16154551 | doi = 10.1016/j.cardiores.2005.07.013 | doi-access = free }}</ref> |
||
== References == |
== References == |
||
Line 51: | Line 63: | ||
[[Category:Lactams]] |
[[Category:Lactams]] |
||
[[Category:Isoindolines]] |
[[Category:Isoindolines]] |
||
[[Category:Carboxylic acids]] |
|||
{{blood-drug-stub}} |
{{blood-drug-stub}} |
||
[[pl:Indobufen]] |
|||
[[pt:Indobufeno]] |